Figure 7
From: Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells
Effect of T0901317 Treatment on an FXR-dependent gene, short heterodimer partner (SHP) in ovarian carcinoma cells. (A) Whole-cell lysates of HS68, A2780, CaOV3 and SKOV3 cells were obtained and subjected to immunoblotting. Fifty micrograms of lysate were loaded per lane and the blot was probed with anti-FXR antibody. (B) CaOV3 cells were treated with T0901317 for 24 hours and SHP gene mRNA expression was examined by real time RT-PCR. (*P < 0.001)